BIOMAT Database Logo BIOMAT Database Logo

Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation. 1999

F Keil, and P Kalhs, and X Chen, and O A Haas, and G Fritsch, and A Chott, and K Lechner, and K Moser, and J Ackermann, and W Rabitsch, and N Worel, and C Mannhalter, and H T Greinix
Department of Medicine 1, Bone Marrow Transplantation Unit, University of Vienna, Austria. felix.keil@akh-wien.ac.at

A large group of patients relapsing after allogeneic bone marrow transplantation (BMT) have obtained remission after infusion of leukocytes from their original donor, suggesting a graft-versus-myeloma effect. However, side effects such as graft-versus-host disease and myelosuppression are severe, and sometimes fatal, complications of this therapeutic approach. Previously we demonstrated that patients with leukemia who lack donor hematopoiesis in relapse after BMT experience severe and lasting aplasia after infusion of donor leukocytes. In two patients - one with extramedullary and one with marrow relapse after a sex-mismatched transplantation - we analyzed hematopoietic chimerism by cell sorting and bone marrow cultures. CD34-positive cells, CD4-CD8-positive cells, committed progenitors, and LTC-IC were of donor origin, as demonstrated by two-color fluorescence in situ hybridization (FISH). Additionally, in relapse complete donor T-cell chimerism was seen. In contrast, plasma cells were of recipient origin in the patient who had a relapse in the bone marrow. Both patients were treated with infusions of donor leukocytes from their original donor. Neither patient suffered myelosuppression, and one achieved a stable complete remission.

UI MeSH Term Description Entries
D007937 Leukapheresis The preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor. Leukocytapheresis,Leukopheresis,Lymphapheresis,Lymphocytapheresis,Leukocytopheresis,Lymphocytopheresis,Lymphopheresis,Leukaphereses,Leukocytaphereses,Leukocytophereses,Leukophereses,Lymphaphereses,Lymphocytaphereses,Lymphocytophereses,Lymphophereses
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D005260 Female Females
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F Keil, and P Kalhs, and X Chen, and O A Haas, and G Fritsch, and A Chott, and K Lechner, and K Moser, and J Ackermann, and W Rabitsch, and N Worel, and C Mannhalter, and H T Greinix
[Allogeneic bone marrow transplantation for refractory multiple myeloma: presence of a graft-versus-myeloma effect].
June 2001, [Rinsho ketsueki] The Japanese journal of clinical hematology,
F Keil, and P Kalhs, and X Chen, and O A Haas, and G Fritsch, and A Chott, and K Lechner, and K Moser, and J Ackermann, and W Rabitsch, and N Worel, and C Mannhalter, and H T Greinix
Bone marrow mesenchymal stem cells chimerism after allogeneic hematopoietic transplantation.
January 2006, Experimental hematology,
F Keil, and P Kalhs, and X Chen, and O A Haas, and G Fritsch, and A Chott, and K Lechner, and K Moser, and J Ackermann, and W Rabitsch, and N Worel, and C Mannhalter, and H T Greinix
Autologous red cell recovery and relapse of multiple myeloma after bone marrow transplantation: is this a graft-versus-myeloma effect?
March 1996, Bone marrow transplantation,
F Keil, and P Kalhs, and X Chen, and O A Haas, and G Fritsch, and A Chott, and K Lechner, and K Moser, and J Ackermann, and W Rabitsch, and N Worel, and C Mannhalter, and H T Greinix
Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect.
February 1997, Leukemia,
F Keil, and P Kalhs, and X Chen, and O A Haas, and G Fritsch, and A Chott, and K Lechner, and K Moser, and J Ackermann, and W Rabitsch, and N Worel, and C Mannhalter, and H T Greinix
T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect.
August 2001, Blood,
F Keil, and P Kalhs, and X Chen, and O A Haas, and G Fritsch, and A Chott, and K Lechner, and K Moser, and J Ackermann, and W Rabitsch, and N Worel, and C Mannhalter, and H T Greinix
Leukemia relapse in donor cells after allogeneic bone-marrow transplantation.
March 1981, The New England journal of medicine,
F Keil, and P Kalhs, and X Chen, and O A Haas, and G Fritsch, and A Chott, and K Lechner, and K Moser, and J Ackermann, and W Rabitsch, and N Worel, and C Mannhalter, and H T Greinix
Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.
April 1997, Bone marrow transplantation,
F Keil, and P Kalhs, and X Chen, and O A Haas, and G Fritsch, and A Chott, and K Lechner, and K Moser, and J Ackermann, and W Rabitsch, and N Worel, and C Mannhalter, and H T Greinix
Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusions.
January 1997, Cancer treatment and research,
F Keil, and P Kalhs, and X Chen, and O A Haas, and G Fritsch, and A Chott, and K Lechner, and K Moser, and J Ackermann, and W Rabitsch, and N Worel, and C Mannhalter, and H T Greinix
Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation.
November 1997, Blood,
F Keil, and P Kalhs, and X Chen, and O A Haas, and G Fritsch, and A Chott, and K Lechner, and K Moser, and J Ackermann, and W Rabitsch, and N Worel, and C Mannhalter, and H T Greinix
[Allogeneic bone marrow transplantation in multiple myeloma].
October 1989, Haematologica,
Copied contents to your clipboard!